Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.44B |
| 2 |
Microsoft
MSFT
|
+$556M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$433M |
| 4 |
Johnson & Johnson
JNJ
|
+$349M |
| 5 |
Amazon
AMZN
|
+$340M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$873M |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$799M |
| 3 |
Colgate-Palmolive
CL
|
+$602M |
| 4 |
Palo Alto Networks
PANW
|
+$574M |
| 5 |
iShares US Real Estate ETF
IYR
|
+$405M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.33% |
| 2 | Financials | 13.77% |
| 3 | Healthcare | 12.44% |
| 4 | Consumer Discretionary | 10.89% |
| 5 | Communication Services | 7.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Invesco DB Agriculture Fund
DBA
$1.24B
| $3.82M | ﹤0.01% |
190,956
-170,906
| -47% | -$3.45M |
|
1302
NNN REIT
NNN
$9.03B
| $3.82M | ﹤0.01% |
95,735
+37,564
| +65% | +$1.7M |
|
1303
JetBlue
JBLU
$2.35B
| $3.81M | ﹤0.01% |
575,475
+296,461
| +106% | +$2.41M |
|
|
BLUE
1304
DELISTED
bluebird bio
BLUE
| $3.81M | ﹤0.01% |
30,103
+24,401
| +428% | +$2.76M |
|
1305
Dillards
DDS
$9.57B
| $3.77M | ﹤0.01% |
13,843
-4,591
| -25% | -$1.21M |
|
1306
TAL Education Group
TAL
$6.7B
| $3.77M | ﹤0.01% |
763,662
+215,898
| +39% | +$1.07M |
|
1307
Veracyte
VCYT
$3.58B
| $3.76M | ﹤0.01% |
226,640
+198,779
| +713% | +$4.47M |
|
1308
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.66B
| $3.75M | ﹤0.01% |
+59,182
| New | +$3.98M |
|
1309
AMN Healthcare
AMN
$1.28B
| $3.75M | ﹤0.01% |
35,346
-11,627
| -25% | -$1.27M |
|
|
DCRD
1310
DELISTED
Decarbonization Plus Acquisition Corporation IV Class A Ordinary Share
DCRD
| $3.74M | ﹤0.01% |
372,813
| – | – |
|
1311
Iovance Biotherapeutics
IOVA
$1.93B
| $3.74M | ﹤0.01% |
390,606
+347,191
| +800% | +$4M |
|
1312
LCI Industries
LCII
$2.52B
| $3.73M | ﹤0.01% |
36,728
-4,019
| -10% | -$489K |
|
|
SNV
1313
DELISTED
Synovus
SNV
| $3.73M | ﹤0.01% |
99,313
+8,442
| +9% | +$335K |
|
1314
SEI Investments
SEIC
$12.5B
| $3.73M | ﹤0.01% |
75,951
-9,321
| -11% | -$509K |
|
1315
Box
BOX
$4.39B
| $3.72M | ﹤0.01% |
152,418
+53,677
| +54% | +$1.48M |
|
|
DGNU
1316
DELISTED
Dragoneer Growth Opportunities Corp. III Class A Ordinary Shares
DGNU
| $3.71M | ﹤0.01% |
379,358
+75,000
| +25% | +$733K |
|
1317
Liberty Global Class A
LBTYA
$3.71B
| $3.71M | ﹤0.01% |
237,704
+73,394
| +45% | +$1.48M |
|
1318
Magnolia Oil & Gas
MGY
$5.96B
| $3.7M | ﹤0.01% |
186,786
+79,558
| +74% | +$1.76M |
|
|
DHAI
1319
DELISTED
DIH Holdings US
DHAI
| $3.7M | ﹤0.01% |
14,762
+2,110
| +17% | +$526K |
|
1320
Highwoods Properties
HIW
$3.67B
| $3.69M | ﹤0.01% |
136,954
+17,174
| +14% | +$555K |
|
|
GFLU
1321
DELISTED
GFL Environmental Inc. Tangible Equity Units
GFLU
| $3.68M | ﹤0.01% |
63,624
+25,000
| +65% | +$1.57M |
|
1322
Editas Medicine
EDIT
$407M
| $3.67M | ﹤0.01% |
300,227
+278,208
| +1,263% | +$4.33M |
|
1323
Keros Therapeutics
KROS
$200M
| $3.67M | ﹤0.01% |
97,575
+63,658
| +188% | +$2.21M |
|
1324
EastGroup Properties
EGP
$11.2B
| $3.65M | ﹤0.01% |
25,307
-5,520
| -18% | -$901K |
|
|
DDL
1325
Dingdong
DDL
$542M
| $3.64M | ﹤0.01% |
1,023,393
| – | – |
|
Similar funds
Barclays's Q3 2022 Portfolio in Review
As of Q3 2022, Barclays held 5,400 positions worth $91.6B, down 44% from $163B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Barclays withdrew a net $66.4B in Q3 2022, closing 533 positions and reducing 1,954 holdings. Its most notable exit was Vonage Holdings Corporation, an estimated $99.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Barclays opened a new position in Pacer iPath Gold ETNs worth $27.1M.
- Barclays's largest Q3 2022 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $27.1M.
- Barclays added most to Apple in Q3 2022, an estimated $1.44B increase.
- Barclays's biggest Q3 2022 reduction was Invesco QQQ Trust, cutting an estimated $873M.
- Barclays fully exited Vonage Holdings Corporation in Q3 2022, selling an estimated $99.4M.
- Barclays's ten largest holdings make up 22% of its $91.6B portfolio in Q3 2022.
- Barclays opened 261 new positions and closed 533 in Q3 2022.
- Barclays's portfolio value fell 44% quarter-over-quarter to $91.6B.
Based on Barclays's 13F filing for Q3 2022, filed 3 Nov 2022.